{"url_path":"/sec/avns/8-k/2026-07-22/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000096-index.html","accession_number":"0001606498-26-000096","cik":"0001606498","ticker":"AVNS","issuer_name":"AVANOS MEDICAL, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000096-index.html","primary_entity_key":"0001606498","primary_entity_name":"AVANOS MEDICAL, INC."},"word_count":152,"has_tables":true,"body_markdown":"Item 7.01    Regulation FD Disclosure\n\nOn July 22, 2026, the Company issued a press release announcing the approval and adoption of the Merger Agreement, and the approval of the transactions contemplated thereby, by the Company’s stockholders at the Special Meeting. A copy of the press release is attached to this Current Report as Exhibit 99.1 and is incorporated herein by reference.\n\nThe information furnished pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing."}